Cargando…

Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint

Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Monica, Walia, Kamini, Bansal, Nitin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823287/
https://www.ncbi.nlm.nih.gov/pubmed/36644017
http://dx.doi.org/10.33393/dti.2022.2532
_version_ 1784866122830446592
author Sharma, Monica
Walia, Kamini
Bansal, Nitin
author_facet Sharma, Monica
Walia, Kamini
Bansal, Nitin
author_sort Sharma, Monica
collection PubMed
description Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes.
format Online
Article
Text
id pubmed-9823287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AboutScience
record_format MEDLINE/PubMed
spelling pubmed-98232872023-01-12 Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint Sharma, Monica Walia, Kamini Bansal, Nitin Drug Target Insights Short Communication Drug-resistant infections are a serious threat globally which demands cost-effective solutions to meet the unmet needs in their diagnosis and treatment. Gram-negative pathogens, drug-resistant tuberculosis, and multidrug-resistant Salmonella typhi have been reported as cause of resistant infections in developing countries. Here, we discuss the priority pathogens and conditions for which feasible solutions adaptable to low-resource settings are required to address the antimicrobial resistance in pathogens. These solutions will be helpful in containing the spread of antimicrobial resistance and better patient outcomes. AboutScience 2022-12-31 /pmc/articles/PMC9823287/ /pubmed/36644017 http://dx.doi.org/10.33393/dti.2022.2532 Text en Copyright © 2022, The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/© 2022 The Authors. This article is published by AboutScience and licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Commercial use is not permitted and is subject to Publisher’s permissions. Full information is available at www.aboutscience.eu (http://www.aboutscience.eu)
spellingShingle Short Communication
Sharma, Monica
Walia, Kamini
Bansal, Nitin
Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title_full Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title_fullStr Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title_full_unstemmed Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title_short Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
title_sort unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823287/
https://www.ncbi.nlm.nih.gov/pubmed/36644017
http://dx.doi.org/10.33393/dti.2022.2532
work_keys_str_mv AT sharmamonica unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint
AT waliakamini unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint
AT bansalnitin unmetneedsformanagementofdrugresistantinfectionslowandmiddleincomecountriesviewpoint